144 related articles for article (PubMed ID: 4177467)
1. Ten years' experience of sterioid assays in the management of breast cancer. A review.
Atkins H; Bulbrook RD; Falconer MA; Hayward JL; MacLean KS; Schurr PH
Lancet; 1968 Dec; 2(7581):1255-60. PubMed ID: 4177467
[No Abstract] [Full Text] [Related]
2. The treatment of advanced breast cancer.
Ackland TH
Med J Aust; 1969 Oct; 2(15):733-41. PubMed ID: 4900529
[No Abstract] [Full Text] [Related]
3. [Steroids and breast cancer. Pharmacologic and therapeutic introduction].
Sala G; Perrotta P
Minerva Ginecol; 1970 Jul; 22(13):669-76. PubMed ID: 4921252
[No Abstract] [Full Text] [Related]
4. Clinical control of metastases in patients with advanced cancer of the breast.
Sellwood RA; Burn I; Fotherby K
Proc R Soc Med; 1974 Sep; 67(9):854-7. PubMed ID: 4610590
[No Abstract] [Full Text] [Related]
5. Hormone therapy of breast cancer with special reference to masteril therapy.
Helman P; Bennett MB
S Afr Med J; 1972 Aug; 46(34):1195-9. PubMed ID: 5068714
[No Abstract] [Full Text] [Related]
6. Hormonal influences in breast cancer.
Forrest AP
Proc R Soc Med; 1971 May; 64(5):509-16. PubMed ID: 4252687
[No Abstract] [Full Text] [Related]
7. Some hormonal and genetic aspects of human breast cancer--a review.
Rajendran KG; Ghosh SN; Seshadri R; Bagli NP; Shah PN
Indian J Cancer; 1973 Mar; 10(1):111-23. PubMed ID: 4576783
[No Abstract] [Full Text] [Related]
8. Urinary steroids in breast cancer.
Nature; 1969 Jan; 221(5177):218. PubMed ID: 5763075
[No Abstract] [Full Text] [Related]
9. [Current problems in the therapy of diffuse breast carcinoma].
Di Pietro S
Minerva Radiol; 1968 Oct; 13(10):569-73. PubMed ID: 5734810
[No Abstract] [Full Text] [Related]
10. Probability of a woman with advanced breast cancer responding to adrenalectomy or hypophysectomy.
Sarfaty G; Tallis M
Lancet; 1970 Oct; 2(7675):685-7. PubMed ID: 4195930
[No Abstract] [Full Text] [Related]
11. Editorial: Breast cancer and the discriminant.
Br Med J; 1975 Apr; 2(5963):107-8. PubMed ID: 1125696
[No Abstract] [Full Text] [Related]
12. Prognostic significance of oestrogen uptake by human breast-cancer tissue.
Braunsberg H; James VH; Irvine WT; Jamieson CW; James F; Sellwood RA; Carter AE; Hulbert M
Lancet; 1973 Jan; 1(7796):163-5. PubMed ID: 4118790
[No Abstract] [Full Text] [Related]
13. Urinary steroids in the prediction of response to adrenalectomy or hypophysectomy. A second clinical trial.
Atkins H; Bulbrook RD; Falconer MA; Hayward JL; MacLean KC; Schurr PH
Lancet; 1968 Dec; 2(7581):1261-3. PubMed ID: 4177468
[No Abstract] [Full Text] [Related]
14. [Antineoplastic polychemotherapy in thoracic pathology].
Mannes P; Derriks R; Moens R; Heynen E
Poumon Coeur; 1968; 24(1):83-91. PubMed ID: 4968018
[No Abstract] [Full Text] [Related]
15. A multidisciplined approach for the treatment of metastatic carcinoma of the breast.
Oberfield RA; Nesto R; Cady B; Pazianos AG; Salzman FA
Med Clin North Am; 1975 Mar; 59(2):425-30. PubMed ID: 46945
[TBL] [Abstract][Full Text] [Related]
16. [Hypophysiolysis by radioactive yttrium implantation in treatment of advanced breast cancer: 10 years' record].
Juret P
Probl Actuels Endocrinol Nutr; 1969; 13():373-93. PubMed ID: 5404030
[No Abstract] [Full Text] [Related]
17. THE MANAGEMENT OF DISSEMINATED CANCER OF THE BREAST.
THORLAKSON TK
Winnipeg Clin Q; 1964 Mar; 17():9-21. PubMed ID: 14133561
[No Abstract] [Full Text] [Related]
18. Some aspects of chemotherapy in breast carcinomatosis.
Arthur K
Clin Radiol; 1968 Jul; 19(3):351-6. PubMed ID: 4175702
[No Abstract] [Full Text] [Related]
19. [17-Hydroxycorticoid excretion in breast carcinoma].
Heise E; Görlich M
Arch Geschwulstforsch; 1973; 41(1):43-51. PubMed ID: 4700695
[No Abstract] [Full Text] [Related]
20. Breast cancer--the Bullbrook discriminant.
Meyer KK
Rocky Mt Med J; 1968 Oct; 65(10):53-9. PubMed ID: 5681761
[No Abstract] [Full Text] [Related]
[Next] [New Search]
